Halozyme Therapeutics, Inc. (HALO)
69.86
-0.50
(-0.71%)
USD |
NASDAQ |
Feb 25, 14:08
Halozyme Therapeutics Price : 69.86 for Feb. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 244.95 |
| Merck & Co., Inc. | 122.37 |
| Skye Bioscience, Inc. | 0.7482 |
| AIM ImmunoTech, Inc. | 1.03 |
| Stryker Corp. | 384.01 |
Price Related Metrics
| PE Ratio | 28.04 |
| PS Ratio | 6.138 |
| Price to Book Value | 168.90 |
| Price to Free Cash Flow | 13.30 |
| Earnings Yield | 3.57% |
| Market Cap | 8.245B |
| Operating PE Ratio | 10.50 |
| Normalized PE Ratio | 15.22 |